Betamethasone valerate 0.1% cream Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

phoenix healthcare distribution ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

Betamethasone valerate 0.1% cream Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

waymade healthcare plc - betamethasone valerate - cutaneous cream - 1mg/1gram

Audavate RD 0.025% cream Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

audavate rd 0.025% cream

accord-uk ltd - betamethasone valerate - cutaneous cream - 250microgram/1gram

Betamethasone valerate 0.1% cream Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

mawdsley-brooks & company ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

Betamethasone valerate 0.1% cream Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

manx healthcare ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

BETNOVATE CREAM 0.1% Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

betnovate cream 0.1%

glaxosmithkline pharmaceutical sdn. bhd. - betamethasone -

Betnovate Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

betnovate

glaxosmithkline nz limited - betamethasone valerate 0.122%{relative} equivalent to 0.1% betamethasone - lotion - 0.1 % - active: betamethasone valerate 0.122%{relative} equivalent to 0.1% betamethasone excipient: cetomacrogol 1000 cetostearyl alcohol citric acid monohydrate glycerol isopropyl alcohol liquid paraffin methyl hydroxybenzoate purified water sodium citrate dihydrate xanthan gum - betnovate lotion is a potent topical corticosteroid indicated foradults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses. these include the following: ·atopic dermatitis (including infantileatopic dermatitis) ·nummular dermatitis (discoid eczema) ·prurigo nodularis ·psoriasis (excluding widespread plaque psoriasis) ·lichen simplex chronicus (neurodermatitis) and lichen planus ·seborrhoeic dermatitis ·irritant or allergic contact dermatitis ·discoid lupus erythematosus ·insect bite reactions ·miliaria (prickly heat); and ·adjunct to systemic steroid therapy in generalised erythroderma.

BETNOVATE SCALP APPLICATION Izrael - angleščina - Ministry of Health

betnovate scalp application

glaxo smith kline (israel) ltd - betamethasone as valerate - solution - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - steroid responsive dermatoses of the scalp, such as psoriasis, seborrheic capitis and inflammation associated with severe dandruff.

Betnovate Ointment 0.1% w/w Irska - angleščina - HPRA (Health Products Regulatory Authority)

betnovate ointment 0.1% w/w

glaxosmithkline (ireland) limited - betamethasone valerate - ointment - 0.1 percent weight/weight - corticosteroids, potent (group iii); betamethasone

Betnovate RD (Ready Diluted) 0.025% w/w Ointment Irska - angleščina - HPRA (Health Products Regulatory Authority)

betnovate rd (ready diluted) 0.025% w/w ointment

glaxosmithkline (ireland) limited - betamethasone valerate - ointment - 0.025 percent weight/weight - corticosteroids, potent (group iii); betamethasone